Cargando…
Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers
BACKGROUND: Numerous clinical trials have demonstrated that oncolytic viruses can elicit antitumor responses when they are administered directly into localized cancers. However, the treatment of metastatic disease with oncolytic viruses has been challenging due to the inactivation of viruses by comp...
Autores principales: | Reddy, P. Seshidhar, Burroughs, Kevin D., Hales, Laura M., Ganesh, Shanthi, Jones, Brian H., Idamakanti, Neeraja, Hay, Carl, Li, Shawn S., Skele, Kristine L., Vasko, Ann-Jeanette, Yang, Jingping, Watkins, D. Neil, Rudin, Charles M., Hallenbeck, Paul L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261858/ https://www.ncbi.nlm.nih.gov/pubmed/17971529 http://dx.doi.org/10.1093/jnci/djm198 |
Ejemplares similares
-
Oncolytic Seneca Valley Virus: past perspectives and future directions
por: Burke, Michael J
Publicado: (2016) -
Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics
por: Corbett, Virginia, et al.
Publicado: (2022) -
N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection
por: Jayawardena, Nadishka, et al.
Publicado: (2021) -
Intercellular transmission of Seneca Valley virus mediated by exosomes
por: Xu, Guowei, et al.
Publicado: (2020) -
Correction to: Intercellular transmission of Seneca Valley virus mediated by exosomes
por: Xu, Guowei, et al.
Publicado: (2020)